Vol.

No.

April 22, 2022Apr 22, 2022

DOWNLOAD THE PDF

Cover Story

ACS recruitment of NCI’s William Dahut illustrates Karen Knudsen’s strategy

By Paul Goldberg

William L. Dahut, the NCI clinical director, was named chief scientific officer of the American Cancer Society.

Free

Anticipating Ukrainian refugees in U.S., ACS, ASCO, Jefferson expand volunteer corps for cancer care resource hub

By Alice Tracey

Conversation with The Cancer Letter Free

Romania’s Csaba Dégi: We need to be proactive about psychosocial support, because Ukrainians are suffering

By Matthew Bin Han Ong

COVID-19 & Cancer

In-person cancer annual meetings during the COVID-19 pandemic: What you need to know

By Matthew Bin Han Ong

Guest Editorial

National marketing and communications network advances NCI cancer centers’ mission

By Erin McElwain

Cancer History Project Free

Odunsi, Pisters, Platanias, and Ulrich: How immigrating to the U.S. shaped their perspectives on oncology

By Alexandria Carolan

Free In the Archives

Changing the paradigm: How a veterinary oncologist informed knowledge of hypoxia

In Brief

Break Through Cancer announces $50M in grants for collaborative cancer research projects

J. Paul Taylor named scientific director, executive vice president of St. Jude

Sylvester Comprehensive Cancer Center establishes Pancreatic Cancer Research Institute

Vera Bradley Foundation for Breast Cancer makes $12.5M commitment to IU School of Medicine

Mount Sinai receives $500K to enhance pancreatic cancer care

Clinical Roundup

FDA OCE commentary: Cancer burden facing Asian Americans partly caused by racism

Wistar study proposes hypothesis of how Epstein-Barr virus infects host

NEXT Oncology enrolls first patient in Madrid phase I clinical research center

Drugs & Targets

ODAC votes unanimously in support of use of randomized data in PI3K inhibitor trials

FDA grants priority review to Enhertu in previously treated HER2-mutant metastatic NSCLC

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues